Summary & Overview
HCPCS S2054: Transplantation of Multivisceral Organs
HCPCS Level II code S2054 denotes transplantation of multivisceral organs, a complex surgical procedure involving simultaneous transplant of multiple abdominal organs. This code captures a high-acuity, resource-intensive inpatient service typically performed at specialized tertiary care transplant centers. Nationally, multivisceral transplantation is clinically significant because it addresses life-threatening organ failure when single-organ transplants are insufficient, and it has important implications for surgical capacity, transplant waitlists, and specialized postoperative care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of coding context, expected sites of service, and payer coverage considerations. The publication summarizes available benchmarks, common billing modifiers, and clinical context relevant to claims processing and policy review. It also highlights areas where governance and prior authorization practices influence access and reimbursement for major multiorgan transplants.
This national summary is intended to inform billing managers, revenue cycle leaders, and policy analysts about the coding purpose, clinical setting, and payer landscape associated with S2054. Data not available in the input are indicated where applicable.
Billing Code Overview
HCPCS Level II code S2054 describes transplantation of multivisceral organs. This service involves surgical transplantation of multiple abdominal organs as a composite graft (for example, combined liver, pancreas, stomach, and small intestine) and is performed in an operative setting requiring specialized transplant teams.
-
Service type: Major multiorgan transplant surgery
-
Typical site of service: Inpatient hospital, often at tertiary care centers with transplant programs
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient undergoing S2054 (transplantation of multivisceral organs) is an adult with end-stage, irreversible failure of multiple abdominal organs—commonly liver plus stomach, pancreas, small intestine, and sometimes kidney—often after chronic intestinal failure, short bowel syndrome, or extensive splanchnic vascular thrombosis. Presentation includes progressive malnutrition, dependence on total parenteral nutrition with associated liver disease, recurrent catheter-related sepsis, or multiorgan failure from congenital or acquired disorders.
The clinical workflow begins with multidisciplinary evaluation by transplant surgery, hepatology, gastroenterology, transplant infectious disease, nutrition, and psychiatry. Preoperative workup includes imaging (CT/MRI angiography), cardiopulmonary assessment, infectious disease screening, nutritional and immunologic evaluation, and optimization of comorbidities. Organ allocation and donor selection are coordinated through the organ procurement organization. The operative encounter involves en bloc explantation of native viscera and implantation of donor multivisceral grafts in a specialized transplant operating room with experienced surgical, anesthesia, and perfusion teams. Postoperative care occurs in a tertiary ICU with intensive immunosuppression management, infectious prophylaxis, surveillance endoscopy of the graft, and long-term outpatient transplant follow-up for rejection surveillance and functional recovery.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|